BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 18584482)

  • 21. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
    Ren F; Zhang S; Mitchell SH; Butler R; Young CY
    Oncogene; 2000 Apr; 19(15):1924-32. PubMed ID: 10773882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas.
    Siddiqui IA; Zaman N; Aziz MH; Reagan-Shaw SR; Sarfaraz S; Adhami VM; Ahmad N; Raisuddin S; Mukhtar H
    Carcinogenesis; 2006 Apr; 27(4):833-9. PubMed ID: 16387739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
    Jiao ZQ; Lü XZ; Guo YC; Kan B; Xu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):380-6. PubMed ID: 18206010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells.
    Thomas F; Holly JM; Persad R; Bahl A; Perks CM
    Urology; 2011 Aug; 78(2):475.e15-21. PubMed ID: 21676444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
    FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.
    Yu HN; Yin JJ; Shen SR
    J Agric Food Chem; 2004 Feb; 52(3):462-6. PubMed ID: 14759133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
    Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs.
    Landis-Piwowar KR; Kuhn DJ; Wan SB; Chen D; Chan TH; Dou QP
    Int J Mol Med; 2005 Apr; 15(4):735-42. PubMed ID: 15754040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
    Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53.
    Hofmann CS; Sonenshein GE
    FASEB J; 2003 Apr; 17(6):702-4. PubMed ID: 12586742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N; Cheng P; Mukhtar H
    Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin.
    Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H
    Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
    Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ
    Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.